Nine Chapters Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $362K | Buy |
32,300
+18,700
| +138% | +$210K | 0.8% | 49 |
|
|
2017
Q2 | $150K | Sell |
13,600
-27,100
| -67% | -$299K | 1.42% | 37 |
|
|
2017
Q1 | $399K | Buy |
+40,700
| New | +$399K | 0.54% | 67 |
|
|
2016
Q4 | – | Sell |
-15,400
| Closed | -$158K | – | 200 |
|
|
2016
Q3 | $158K | Buy |
+15,400
| New | +$158K | 1.11% | 42 |
|
|
2015
Q4 | – | Sell |
-127,800
| Closed | -$887K | – | 812 |
|
|
2015
Q3 | $887K | Sell |
127,800
-13,800
| -10% | -$95.8K | 0.08% | 377 |
|
|
2015
Q2 | $1.39M | Buy |
141,600
+33,700
| +31% | +$331K | 0.12% | 254 |
|
|
2015
Q1 | $956K | Buy |
107,900
+40,800
| +61% | +$361K | 0.08% | 386 |
|
|
2014
Q4 | $588K | Buy |
67,100
+42,900
| +177% | +$376K | 0.05% | 487 |
|
|
2014
Q3 | $167K | Buy |
24,200
+12,700
| +110% | +$87.6K | 0.01% | 877 |
|
|
2014
Q2 | $60K | Buy |
+11,500
| New | +$60K | ﹤0.01% | 903 |
|
|
2013
Q4 | – | Sell |
-10,300
| Closed | -$52K | – | 1019 |
|
|
2013
Q3 | $52K | Buy |
+10,300
| New | +$52K | 0.01% | 715 |
|